How Can Pharmaceutical Companies Increase Sales and Reduce Sampling Costs? | Quantzig’s Latest Success Story Offers Exhaustive Insights

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Oct 11, 2019 11:30 am
LONDON -- 

Quantzig, a global data analytics and advisory firm that delivers actionable analytics solutions to resolve complex business problems, has announced the completion of their latest real world evidence engagement for a pharmaceutical industry client. This success story analyzes the factors that enabled the client to reduce sampling costs and increase sales by 17%.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191011005388/en/

Over the past few years, companies in the pharmaceutical industry have invested considerable resources in real world evidence (RWE) analytics. Differential success rates have been observed, with little consensus on best practices or value potential. However, the most successful pharmaceutical companies have realized substantial value across the product and drug development lifecycle through real world evidence platforms and they are poised to capture sustained value. Also, a few leading pharmaceutical companies have broken new ground with their systematic approach to real world evidence analytics. Such pharmaceutical industry players are implementing real world evidence analytics solutions that move beyond narrow research-based approaches to create sustained value across the product lifecycle and drug development processes.

Request a free brochure of our analytics solutions to learn more about how it can help you identify the right opportunities in your niche market.

The Business Challenge

The client, a leading pharmaceutical manufacturer based out of Germany, wanted to improve the existing market share of their drugs. Also, the client faced stiff competition in the market and needed to improve their reach and marketing strategy to ensure that the physicians prescribe their brand. The client faced challenges that spanned three core areas including:

  • Inability to generate incremental sales and higher returns on investment
  • Lack of analytical capabilities to assess the short-term and long-term impact of marketing efforts
  • Inability to improve their reach and marketing strategy

Real-world evidence analytics enables companies in the pharmaceutical industry to evaluate their ROI and develop new strategies to market products in niche markets,” says an analytics expert from Quantzig.

Talk to our analytics experts and learn how we can help you deliver a unique, intelligent real-world evidence strategy for increased clinical research efficiency and targeted plans.

The Solution Offered & Value Delivered

The pharmaceutical manufacturer collaborated with Quantzig to leverage its expertise in offering real world evidence analytics solutions to better understand the impact of sample allocation in different scenarios and identify key reasons for inappropriate sample distribution across states based on data visualizations in real-time. Quantzig’s real world evidence analytics engagement empowered the pharmaceutical industry client to:

  • Increase sales by 17%
  • Reduce sampling cost by 51%
  • Improve physician satisfaction by 3x

Gain limited-time complimentary access to our analytics platform and learn how we can help you evaluate the cost-effectiveness of therapies to complement clinical trial outcomes using disparate data sources.

Quantzig's real world evidence analytics engagement offered predictive insights on:

  • Improving sales effectiveness based on actionable insights offered on sales growth opportunities
  • Evaluating drug treatment efficacy and cost-effectiveness of therapies

Quantzig’s real world evidence solutions can help you gain insights on treatment pathways, patient adherence, disease progression, market access, drug safety, and patient engagement. Learn more.

Recent Success Stories:

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal

Quantzig
Anirban Choudhury
Marketing Manager
US: +1 630 538 7144
UK: +44 208 629 1455
https://www.quantzig.com/contact-us

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).